ContractAgreement for Reimbursement of Capital Expenditure and Service Fees • May 5th, 2020 • Delaware
Contract Type FiledMay 5th, 2020 JurisdictionEX-10.85 3 opiant_consortxfinalreimba.htm EXHIBIT 10.85 Exhibit 10.85 CONFIDENTIALTREATMENT REQUESTED CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION EXECUTION COPY AGREEMENT FOR REIMBURSEMENT OF CAPITAL EXPENDITURE AND SERVICE FEES BETWEEN AESICA QUEENBOROUGH LIMITED And OPIANT PHARMACEUTICALS INC relating to the development, manufacture and supply of a device capable of administering Nalmefene hydrochloride Exhibit 10.85 Contents CLAUSE
AGREEMENT FOR REIMBURSEMENT OF CAPITAL EXPENDITURE AND SERVICE FEES BETWEEN AESICA QUEENBOROUGH LIMITED And OPIANT PHARMACEUTICALS INC relating to the development, manufacture and supply of a device capable of administering Nalmefene hydrochlorideAgreement for Reimbursement of Capital Expenditure and Service Fees • September 10th, 2018 • Opiant Pharmaceuticals, Inc. • Metal mining • Delaware
Contract Type FiledSeptember 10th, 2018 Company Industry Jurisdiction